Cargando…
Chemotherapy in advanced bladder cancer: current status and future
Bladder cancer occurs in the majority of cases in males. It represents the seventh most common cancer and the ninth most common cause of cancer deaths for men. Transitional cell carcinoma is the most predominant histological type. Bladder cancer is highly chemosensitive. In metastatic setting, chemo...
Autores principales: | Ismaili, Nabil, Amzerin, Mounia, Flechon, Aude |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178536/ https://www.ncbi.nlm.nih.gov/pubmed/21906310 http://dx.doi.org/10.1186/1756-8722-4-35 |
Ejemplares similares
-
Small cell cancer of the bladder: The Leon-Berard cancer centre experience
por: Ismaili, Nabil, et al.
Publicado: (2008) -
Micropapillary bladder cancer: a review of Léon Bérard Cancer Center experience
por: Heudel, Pierre, et al.
Publicado: (2009) -
Outcome of recurrent and metastatic small cell carcinoma of the bladder
por: Ismaili, Nabil, et al.
Publicado: (2009) -
A rare case of advanced testicular seminoma in a 78-year-old man managed successfully with carboplatin based chemotherapy: a case report
por: Ismaili, Nabil, et al.
Publicado: (2008) -
Editorial comment: the effect of neoadjuvant chemotherapy on tumour downstaging and outcomes in patients with muscle invasive bladder cancers
por: Ismaili, Nabil
Publicado: (2020)